More than just cheap drugs

Tripping Up in Qatar

When Boehringer Ingelheim announced in July 2000 that it would provide its Viramune tablets for the prevention of mother-to-child transmission of HIV-1 free of charge to developing countries for five years, the company expected a flood of applications...